| 27.03.2012 |
biolitec AG: Downstream Merger with Relocation to Austria in planning [more] |
| 29.02.2012 |
biolitec AG completes public share buyback program [more] |
| 31.01.2012 |
biolitec AG decides public buyback of up to 500,000 shares at €1.70 [more] |
| 30.11.2011 |
biolitec AG intends to switch from Prime Standard to Entry Standard [more] |
| 28.10.2011 |
biolitec AG: The publication of the group’s annual financial statement 2010/2011 has to be postponed [more] |
| 04.10.2011 |
biolitec AG: biolitec plans transformation into a European Company (SE) [more] |
| 31.05.2011 |
biolitec AG: revenue increased by 19% to 26.1 million Euro in the first three quarters of the fiscal year 2010/11 – Asia and Near East show high sales potentials with 73% growth [more] |
| 28.02.2011 |
biolitec AG increased consolidated revenue in the second quarter of the fiscal year 2010/2011 by 15% to EUR 16.6 million – Gross profit rose by EUR 2 million to EUR 12 million [more] |
| 10.02.2011 |
biolitec AG achieved consolidated revenue of Euro 7.5 million in the first quarter of the fiscal year 2010/2011 – EBIT improved considerably over the previous year [more] |
| 24.01.2011 |
biolitec AG – group turnover 2009/2010 with Euro 30.4 million at previous year’s level – gross profit increases to Euro 19.5 million – dividend recommended [more] |
| 31.05.2010 |
biolitec AG: EBIT rises to 1.5 million Euro in Q3 2009/2010 – biolitec’s medication Foscan® becomes hope for patients with head and neck cancer [more] |
| 26.02.2010 |
biolitec AG back in the profit zone – EBIT rises to Euro 1.46 million in the second quarter 2009/2010 – cost savings take effect [more] |
| 30.11.2009 |
biolitec AG achieved consolidated revenue of Euro 6.2 million for the first three months of the fiscal year 2009/2010 - EBIT rises to Euro 0.63 million [more] |
| 30.09.2009 |
biolitec AG achieved consolidated sales of Euro 30.5 million for the fiscal year 2008/2009 – EBIT amounts to Euro 0.31 million [more] |
| 03.06.2009 |
biolitec AG – Turnover of 23,3 Mio. Euro in the first nine month 2008/09 – Operating results in the third quarter almost balanced [more] |
| 23.03.2009 |
biolitec wins patent infringement case against AMS in US district court – European Urology Association meeting in Stockholm shows strong interest in biolitec's Benign Prostate Hyperplasia treatment device [more] |
| 17.03.2009 |
biolitec agrees settlement with the largest mobile customer for urology laser systems, expects this will result in substantially enhanced market position in the USA [more] |
| 27.02.2009 |
biolitec AG – Turnover of 15.4 Mio Euro in the first six month 2008/09 – Turnover level stabilizes in the second quarter [more] |
| 28.11.2008 |
biolitec AG achieved consolidated revenue of Euro 7.4 million for the first three months of the fiscal year 2008/2009 - EBIT amounts to Euro 0.5 million [more] |
| 30.09.2008 |
biolitec AG achieved consolidated revenue of Euro 35.4 million for the fiscal year 2007/2008 - EBIT amounts to Euro 1.4 million [more] |
| 30.05.2008 |
biolitec AG revenue increases to Euro 28.05 million in the first nine months 07/08 - EBIT amounts to Euro 3.2 million [more] |
| 29.02.2008 |
biolitec AG revenue increases to Euro 19.1 million in the first six months 07/08 - EBIT growth of 23% to Euro 3.0 million [more] |
|
